• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病中的高密度脂蛋白功能。

HDL functionality in type 1 diabetes.

机构信息

Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Department of Vascular Medicine, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Atherosclerosis. 2017 Dec;267:99-109. doi: 10.1016/j.atherosclerosis.2017.10.018. Epub 2017 Oct 21.

DOI:10.1016/j.atherosclerosis.2017.10.018
PMID:29102899
Abstract

Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by absence of insulin secretion due to destruction of the pancreatic beta-cells. Patients with T1D exhibit an increased risk for cardiovascular disease (CVD) compared with non-diabetic subjects. It has been established that low concentration of high-density lipoprotein cholesterol (HDL-C), an independent risk marker of CVD, coincides with a reduced protective capacity against oxidative stress. However, conflicting results have been reported on the prevalence of low HDL-C levels in T1D. Interestingly, changes in composition and function of HDL particles (abnormal ratio of cholesteryl ester-to-triglyceride, reduction in the phospholipid content, reduced capacity to promote cholesterol efflux from macrophages, impaired anti-inflammatory and anti-oxidant activities) have been described in patients with T1D. Hence, exploring HDL function, even in the presence of normal HDL-C levels, might provide additional insight into the underlying pathophysiology associated with increased CV risk in T1D. In the current review, we will provide a detailed overview of the current evidence for a role of HDL function as independent risk factor for the development of CVD in T1D.

摘要

1 型糖尿病(T1D)是一种慢性自身免疫性疾病,其特征是由于胰腺β细胞破坏导致胰岛素分泌不足。与非糖尿病患者相比,T1D 患者患心血管疾病(CVD)的风险增加。已经确定,高密度脂蛋白胆固醇(HDL-C)浓度低是 CVD 的独立风险标志物,与抗氧化应激的保护能力降低有关。然而,关于 T1D 患者低 HDL-C 水平的患病率,已有相互矛盾的报道。有趣的是,在 T1D 患者中已经描述了 HDL 颗粒的组成和功能的变化(胆固醇酯与甘油三酯的比例异常、磷脂含量降低、促进巨噬细胞胆固醇流出的能力降低、抗炎和抗氧化活性受损)。因此,即使在 HDL-C 水平正常的情况下,探索 HDL 功能也可能提供更多关于与 T1D 中 CV 风险增加相关的潜在病理生理学的见解。在当前的综述中,我们将详细概述 HDL 功能作为 T1D 发生 CVD 的独立风险因素的现有证据。

相似文献

1
HDL functionality in type 1 diabetes.1 型糖尿病中的高密度脂蛋白功能。
Atherosclerosis. 2017 Dec;267:99-109. doi: 10.1016/j.atherosclerosis.2017.10.018. Epub 2017 Oct 21.
2
HDL-C: role as a risk modifier.高密度脂蛋白胆固醇(HDL-C):作为风险调节因子的作用
Atheroscler Suppl. 2011 Nov;12(3):267-70. doi: 10.1016/S1567-5688(11)70885-6.
3
Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.脂肪酶、卵磷脂胆固醇酰基转移酶和胆固醇酯转移蛋白在胰岛素抵抗和2型糖尿病异常高密度脂蛋白代谢中的作用
Clin Lab. 2003;49(11-12):601-13.
4
Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.2型糖尿病肥胖患者的甘油三酯与高密度脂蛋白胆固醇比值、血糖控制及心血管风险
Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):150-6. doi: 10.1097/MED.0000000000000241.
5
Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.管理他汀类药物治疗患者与高密度脂蛋白胆固醇和甘油三酯相关的残余心血管疾病风险:临床更新。
Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):799-807. doi: 10.1016/j.numecd.2013.05.002. Epub 2013 Aug 9.
6
Abnormal high-density lipoprotein composition in women with insulin-dependent diabetes.胰岛素依赖型糖尿病女性患者的异常高密度脂蛋白组成
J Lab Clin Med. 1989 Feb;113(2):235-40.
7
Pre-β1 HDL in type 2 diabetes mellitus.2 型糖尿病中的前β1 高密度脂蛋白。
Atherosclerosis. 2017 Aug;263:24-28. doi: 10.1016/j.atherosclerosis.2017.05.031. Epub 2017 May 25.
8
[Diabetic dyslipidaemia and the atherosclerosis].[糖尿病血脂异常与动脉粥样硬化]
Orv Hetil. 2016 May 8;157(19):746-52. doi: 10.1556/650.2016.30441.
9
The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.2型糖尿病中的脂质三联征——2型糖尿病中高甘油三酯血症/低高密度脂蛋白综合征的患病率及相关性
Exp Clin Endocrinol Diabetes. 2004 Feb;112(2):75-9. doi: 10.1055/s-2004-815753.
10
[Low HDL-cholesterol--an important risk factor for cardiovascular diseases].低高密度脂蛋白胆固醇——心血管疾病的一个重要危险因素
Lijec Vjesn. 2011 Mar-Apr;133(3-4):111-6.

引用本文的文献

1
HDL metabolism and function in diabetes mellitus.糖尿病中的高密度脂蛋白代谢与功能
Nat Rev Endocrinol. 2025 Sep 17. doi: 10.1038/s41574-025-01176-y.
2
High-density lipoproteins. Part 2. Impact of disease states on functionality.高密度脂蛋白。第2部分。疾病状态对功能的影响。
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
3
Type 1 diabetes mellitus (T1DM) does not affect whole blood responses to alginate-based microspheres despite plasma lipid and glucose differences.尽管存在血浆脂质和葡萄糖差异,但1型糖尿病(T1DM)并不影响全血对藻酸盐微球的反应。
Mater Today Bio. 2025 Jul 18;34:102113. doi: 10.1016/j.mtbio.2025.102113. eCollection 2025 Oct.
4
Clinical remission in newly diagnosed type 1 diabetes mellitus and HDL function on cholesterol efflux capacity: prospective InLipoDiab1 study.新诊断1型糖尿病的临床缓解与高密度脂蛋白对胆固醇流出能力的作用:前瞻性InLipoDiab1研究
Endocr Connect. 2025 Jun 17;14(6). doi: 10.1530/EC-24-0704. Print 2025 Jun 1.
5
The Prognostic Significance of the DBIL/HDLC Ratio in Patients With Dilated Cardiomyopathy.直接胆红素与高密度脂蛋白胆固醇比值在扩张型心肌病患者中的预后意义
Cardiovasc Ther. 2025 Feb 15;2025:8835736. doi: 10.1155/cdr/8835736. eCollection 2025.
6
The Effects of Exercise Training on Body Composition and Cardiometabolic Risk Factors in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.运动训练对1型糖尿病患者身体成分和心血管代谢危险因素的影响:一项系统评价和荟萃分析
Healthcare (Basel). 2025 Jan 26;13(3):246. doi: 10.3390/healthcare13030246.
7
Evaluation of the Steno Type 1 Risk Engine in predicting cardiovascular events in an ethnic mixed population of type 1 diabetes mellitus and its association with chronic microangiopathy complications.评估 Steno Type 1 风险引擎在预测 1 型糖尿病的种族混合人群中心血管事件中的作用及其与慢性微血管并发症的关系。
Cardiovasc Diabetol. 2024 Oct 22;23(1):374. doi: 10.1186/s12933-024-02460-3.
8
The Endogenous Inhibitor of CETP, apoC1, Remains Ineffective In Vivo after Correction of Hyperglycemia in People with Type 1 Diabetes.CETP的内源性抑制剂载脂蛋白C1在1型糖尿病患者血糖纠正后体内仍无效。
Metabolites. 2024 Sep 7;14(9):487. doi: 10.3390/metabo14090487.
9
2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders.波兰实验室诊断学会和波兰脂质协会2024年脂质代谢紊乱实验室诊断指南。
Arch Med Sci. 2024 Mar 18;20(2):357-374. doi: 10.5114/aoms/186191. eCollection 2024.
10
High-density lipoprotein in diabetes: Structural and functional relevance.糖尿病中的高密度脂蛋白:结构与功能相关性。
J Diabetes Investig. 2024 Jul;15(7):805-816. doi: 10.1111/jdi.14172. Epub 2024 Feb 28.